APC
QTTB icon

Aspire Private Capital’s Q32 Bio QTTB Stock Holding History

Aspire Private Capital’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17
Closed -$378 – 684
2022
Q4 		$378 Hold
17
– – ﹤0.01% 606
2022
Q3 		$0 Sell
17
-15
-47% -$612 ﹤0.01% 671
2022
Q2 		$1K Buy
32
+21
+191% +$717 ﹤0.01% 587
2022
Q1 		$1K Hold
11
– – ﹤0.01% 580
2021
Q4 		$1K Hold
11
– – ﹤0.01% 616
2021
Q3 		$2K Hold
11
– – ﹤0.01% 516
2021
Q2 		$1K Buy
+11
New +$1.37K ﹤0.01% 569

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Aspire Private Capital's QTTB Position: Q1 2023 in Review

Aspire Private Capital sold out of Q32 Bio (QTTB) in Q1 2023, closing a stake of 17 shares — an estimated $378 sold.

Aspire Private Capital first reported a position in QTTB in Q2 2021 and held it in 7 quarters. The position peaked at $2K in Q3 2021. 62 funds tracked by Wall St. Rank hold QTTB as of Q1 2023.

  • Aspire Private Capital reported no remaining Q32 Bio position as of Q1 2023 after selling out during the quarter.
  • Aspire Private Capital sold 17 Q32 Bio shares in Q1 2023, an estimated $378.
  • Aspire Private Capital first reported a position in Q32 Bio in Q2 2021 and held it in 7 quarters.
  • Aspire Private Capital's Q32 Bio position peaked at $2K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2023.

Based on Aspire Private Capital's 13F filing for Q1 2023, filed 3 May 2023.